GSK Insider Buying & Government Contracts (2026)
Quick Facts & Defense Contracting Direct Answers
How much does GSK plc receive in federal government contracts?
GSK plc has been awarded over $45.5M in tracked prime federal obligations across 1 awarding agencies spanning 2 active contracts, as recorded in official FPDS and USAspending data.
Which congressional lawmakers trade GSK plc (GSK) stock?
Public Periodic Transaction Reports (PTR) under the STOCK Act record transactions in GSK plc (GSK) by members of Congress including Virginia Foxx, Lisa C Mcclain, Bruce Westerman.
How are federal defense contracts mapped to GSK plc on Gemral Edge?
Gemral Edge programmatically reconciles prime award obligations from SAM.gov, USAspending, and FPDS through corporate parent CAGE and UEI hierarchies directly to ticker GSK.
Major Federal & Defense Procurement Contracts
Recent prime contract obligations, delivery orders, and modifications awarded to GSK plc:
| Action Date | Awarding Agency | Obligated Amount | Award ID | Contract Description |
|---|---|---|---|---|
| 2026-09-25 | Department of Health and Human Services | $45.5M | CONT_AWD_75A50325C00019_7505_-NONE-_-NONE- | RELENZA (ZANAMIVIR) ROTADISK, 5MG |
| 2026-09-01 | Department of Health and Human Services | $22.9M | CONT_AWD_75A50122F61004_7505_75A50122D00002_7505 | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA |
GSK plc (GSK) is an active recipient of U.S. federal and defense procurement awards. According to federal procurement records and obligation filings, the company has been awarded 2 prime federal contracts and delivery orders totaling approximately $45.5M across 1 federal awarding agencies, with the most recent award action registered on 2026-09-25.
Federal contracts represent substantial multi-year revenue visibility for prime contractors and defense suppliers. Gemral Edge continuously reconciles federal award obligations from the Federal Procurement Data System (FPDS) and USAspending with congressional disclosures, tracking capital flow from policy authorization through corporate execution.
Verified from official public disclosure — record GSK-CONGRESS-DISCLOSURE
Unified Ticker Intelligence Dossier (GSK)
Synthesis: Mã GSK ghi nhận dữ liệu hoạt động tổng hợp qua các kênh công quyền và dòng tiền.
Temporal Context: Ghi nhận sự kiện và luồng thông tin mới trong 365 ngày qua đối với GSK.
Data Coverage & Verification: Overall coverage score: 67% across 6 pillars (Government, Policy, Flow, Management, Catalysts, Historical). Verified by 3 independent statutory data sources.
Congressional Stock Trading Activity in GSK
Disclosed stock purchases and sales by members of Congress and spouses involving GSK plc securities under the STOCK Act:
| Lawmaker | Party-State | Chamber | Transaction Date | Action | Disclosed Range | Est. Return |
|---|---|---|---|---|---|---|
| Lisa C. McClain | R-MI | HOUSE | 2025-10-31 | SELL | $1K – $15K | +9.3% |
| Lisa C. McClain | R-MI | HOUSE | 2025-10-30 | SELL | $1K – $15K | +9.1% |
| Lisa C. McClain | R-MI | HOUSE | 2025-10-30 | BUY | $1K – $15K | +9.1% |
| Val T. Hoyle | D-OR | HOUSE | 2025-09-23 | SELL | $1K – $15K | +26.4% |
| Lisa C. McClain | R-MI | HOUSE | 2025-08-04 | BUY | $1K – $15K | +35.9% |
| Val T. Hoyle | D-OR | HOUSE | 2024-11-18 | BUY | $1K – $15K | +52.0% |
| Robert B. Aderholt | R-AL | HOUSE | 2025-07-28 | SELL | $1K – $15K | +36.7% |
| Lisa C. McClain | R-MI | HOUSE | 2025-06-24 | SELL | $1K – $15K | +32.4% |
| Lisa C. McClain | R-MI | HOUSE | 2025-06-17 | BUY | $1K – $15K | +28.9% |
| Bruce Westerman | R-AR | HOUSE | 2025-04-21 | SELL | $1K – $15K | +40.5% |
| Bruce Westerman | R-AR | HOUSE | 2025-03-03 | BUY | $1K – $15K | +34.9% |
| Marjorie Taylor Greene | R-GA | HOUSE | 2024-11-25 | BUY | $1K – $15K | +50.0% |
| Tommy Tuberville | R-AL | SENATE | 2023-10-16 | SELL | $1K – $15K | +40.0% |
| Daniel S. Goldman | D-NY | HOUSE | 2023-07-10 | SELL | $15K – $50K | +51.3% |
| Tommy Tuberville | R-AL | SENATE | 2023-04-03 | BUY | $1K – $15K | +42.5% |
Which congressional committees and active lawmakers are linked to this sector?
Disclosed lawmakers and congressional committees holding policy jurisdiction, defense appropriations oversight, or direct capital exposure in GSK:
- Lisa C. McClain (House) — Disclosed STOCK Act transactions (R-MI)
- Val T. Hoyle (House) — Disclosed STOCK Act transactions (D-OR)
- Robert B. Aderholt (House) — Disclosed STOCK Act transactions (R-AL)
- Bruce Westerman (House) — Disclosed STOCK Act transactions (R-AR)
- Marjorie Taylor Greene (House) — Disclosed STOCK Act transactions (R-GA)
- Tommy Tuberville (Senate) — Disclosed STOCK Act transactions (R-AL)
- Daniel S. Goldman (House) — Disclosed STOCK Act transactions (D-NY)
- Virginia Foxx (House) — Disclosed STOCK Act transactions (R-NC)
Latest Real-Time Intelligence & Breaking Events
Live contract obligations, SEC filings, and procurement intelligence for GSK plc are monitored 24/7 on Gemral Edge Breaking News and Defense Radar.
Federal Contracting Dynamics & Government Revenue Exposure
Government contracting for defense and enterprise infrastructure follows strict Federal Acquisition Regulation (FAR) guidelines, often spanning multi-year base periods with optional extension years. Monitoring prime contractor award velocity provides institutional investors and market participants with un-lagged visibility into backlog expansion, agency budget priorities, and defense authorization funding flows.
Furthermore, when members of congressional defense, intelligence, or appropriations committees disclose trading activity in major federal contractors such as GSK plc, cross-referencing contract award timelines with legislative disclosures highlights important intersections of public policy and corporate performance.
Frequently asked questions
How much does GSK plc receive in federal government contracts?
GSK plc holds over $45.5M in tracked federal obligations across 1 public agencies, providing multi-year revenue visibility across defense and civilian procurement budgets.
Which congressional lawmakers trade GSK plc (GSK) stock?
GSK plc (GSK) stock transactions have been disclosed by members of Congress including Virginia Foxx, Lisa C Mcclain, Bruce Westerman, Tommy Tuberville. Disclosures filed under the STOCK Act detail execution dates, asset classes, and statutory valuation ranges.
How are federal defense contracts resolved to GSK plc?
Gemral Edge maps prime award notices from the Federal Procurement Data System (FPDS) and USAspending through Ultimate Parent CAGE and UEI corporate hierarchies directly to parent ticker GSK.
What technology stack signals are detected for GSK plc?
Active talent hiring requisitions and engineering role profiles are continuously monitored across public corporate job postings to track enterprise software adoption and technology migration patterns.
Data intelligence from public filings — not investment advice.
Explore Gemral Edge
- Lawmaker trading GSK
- Lawmaker trading GSK
- Lawmaker trading GSK
- Lawmaker trading GSK
- Lawmaker trading GSK
- Robert B. Aderholt — stock portfolio
- Marjorie Taylor Greene — stock portfolio
- September 2026 CPI Report: Release Date & Forecast
- US Election Betting Odds & Stock Impact Tracker
- U.S. Recession Odds 2027: Indicators & Liquidity Forecast
- Capitol Trades leaderboard
- Federal contract explorer
- Lobbying velocity index
- Live signal radar
- Macro & liquidity radar
- 2026 Senate battleground
Risk Disclaimer
Trading and investing in digital assets, financial instruments, and predictive events involve substantial risk of loss and are not suitable for every investor. The predictive intelligence, probability distributions, historical precedents, and scenario modeling presented on this page are compiled for informational and research purposes only and do not constitute financial, investment, legal, or tax advice. Past performance and statistical precedents do not guarantee future outcomes. Always conduct independent due diligence before committing capital.